The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) Total Receivables: BDT0.00 Mil (As of . 20)


DHA:IBNSINA The IBN SINA Pharmaceutical Industry PLC DHA:IBNSINA
20 GF Score
Price BDT319.80
View Full Analysis

What is The IBN SINA Pharmaceutical Industry Total Receivables?

The IBN SINA Pharmaceutical Industry DHA:IBNSINA +0.13% 20 Total Receivables is BDT0.00 Mil as of . 20. GuruFocus rates DHA:IBNSINA with a GF Score™ of 20/100.

The IBN SINA Pharmaceutical Industry's Total Receivables for the quarter that ended in . 20 was BDT0.00 Mil.

The IBN SINA Pharmaceutical Industry Total Receivables Related Terms

The IBN SINA Pharmaceutical Industry Total Receivables Historical Data

* Premium members only.

The historical data trend for The IBN SINA Pharmaceutical Industry's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The IBN SINA Pharmaceutical Industry Total Receivables Chart

The IBN SINA Pharmaceutical Industry Annual Data
Trend
Total Receivables

The IBN SINA Pharmaceutical Industry Semi-Annual Data
Total Receivables
DHA:IBNSINA
20GF Score
The IBN SINA Pharmaceutical Industry PLC DHA:IBNSINA
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The IBN SINA Pharmaceutical Industry Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of BDT0.00 Mil mean?
The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) has a Total Receivables of BDT0.00 Mil as of . 20. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on The IBN SINA Pharmaceutical Industry and its competitors.
Is The IBN SINA Pharmaceutical Industry's Total Receivables too high?
The IBN SINA Pharmaceutical Industry's current Total Receivables is BDT0.00 Mil. Overall, The IBN SINA Pharmaceutical Industry has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does The IBN SINA Pharmaceutical Industry's Total Receivables compare to IMNPQ?
The IBN SINA Pharmaceutical Industry's Total Receivables of BDT0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Drug Manufacturers company?
A good Total Receivables depends on the Drug Manufacturers industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on The IBN SINA Pharmaceutical Industry and its competitors. The IBN SINA Pharmaceutical Industry's current Total Receivables is BDT0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The IBN SINA Pharmaceutical Industry stock overvalued right now?
The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) has a current Total Receivables of BDT0.00 Mil. The current Total Receivables is BDT0.00 Mil. The IBN SINA Pharmaceutical Industry's overall GF Score™ is 20/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For The IBN SINA Pharmaceutical Industry (DHA:IBNSINA), the current Total Receivables is BDT0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The IBN SINA Pharmaceutical Industry Business Description

Address Mirpur Road, Tanin Center, 3 Asad Gate, Mohammadpur, Dhaka, BGD, 1207
The IBN SINA Pharmaceutical Industry PLC is engaged in the production and marketing of pharmaceutical drugs and natural medicines in both the local and international market.
20GF Score

Get the complete analysis for DHA:IBNSINA

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT319.80
Price